| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50242-096-01 | 50242-096 | HUMAN PRESCRIPTION DRUG | VABYSMO | Faricimab | INJECTION, SOLUTION | INTRAVITREAL | 20220128 | N/A | BLA | BLA761235 | Genentech, Inc. | FARICIMAB | 6 mg/.05mL | 1 VIAL in 1 CARTON (50242-096-01) / .05 mL in 1 VIAL (50242-096-03) |
| 50242-096-06 | 50242-096 | HUMAN PRESCRIPTION DRUG | VABYSMO | Faricimab | INJECTION, SOLUTION | INTRAVITREAL | 20240703 | N/A | BLA | BLA761235 | Genentech, Inc. | FARICIMAB | 6 mg/.05mL | 1 SYRINGE in 1 CARTON (50242-096-06) / .05 mL in 1 SYRINGE |
| 50242-096-45 | 50242-096 | HUMAN PRESCRIPTION DRUG | VABYSMO | Faricimab | INJECTION, SOLUTION | INTRAVITREAL | 20240703 | N/A | BLA | BLA761235 | Genentech, Inc. | FARICIMAB | 6 mg/.05mL | 1 SYRINGE in 1 CARTON (50242-096-45) / .05 mL in 1 SYRINGE |
| 50242-096-86 | 50242-096 | HUMAN PRESCRIPTION DRUG | VABYSMO | Faricimab | INJECTION, SOLUTION | INTRAVITREAL | 20220128 | N/A | BLA | BLA761235 | Genentech, Inc. | FARICIMAB | 6 mg/.05mL | 1 VIAL in 1 CARTON (50242-096-86) / .05 mL in 1 VIAL (50242-096-77) |